SSRIs in the treatment of panic disorder

Depression and Anxiety

Volumn 8, Issue SUPPL. 1, 1998, Pages 114-120

  Goddard, Andrew W ^a   Charney, Dennis S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Panic disorder; Serotonin reuptake inhibitors; Treatment

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGORAPHOBIA; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FATIGUE; HUMAN; INSOMNIA; NAUSEA; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; SEXUAL DYSFUNCTION; SWEATING; TREMOR; VERTIGO;

HUMANS; PANIC DISORDER; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0031785884     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:1+<114::AID-DA17>3.0.CO;2-S     Document Type: Article

References (62)

1. APA (American Psychiatric Association) (1980) Diagnostic and Statistical Manual of Mental Disorders - Third Edition. APA, Washington DC.
2. APA (American Psychiatric Association) (1987) Diagnostic and Statistical Manual of Mental Disorders - Third Edition, revised. APA, Washington DC.
3. Asnis GM (1992) Effects of fluvoxamine on the treatment of panic disorder: A placebo-controlled trial. An Psiquiatria 8:78.
4. Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D (1996) A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Psychopharmacol Bull 32:135-141.
5. Beaumont G (1977) A large open multicentre trial of clomipramine (Anafranil) in the management of phobic disorders. J Int Med Res 5:116-23.
6. Black DW, Wesner R, Bowers W, Gabel J (1993a) A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 50:44-50.
7. Black DW, Wesner R, Gabel J (1993b) The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 54:146-149.
8. Blier P, de Montigny C, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S.
9. Boyer W (1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis. Int Clin Psychopharmacol 10:45-49.
10. Burnham DB, Steiner MX, Gergel IP, Oukes R, Binler DC, Wheadon DE (1995) Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: A double-blind study (Poster). American College of Neuropsychopharmacology, San Juan, Puerto Rico.
11. Bystritsky A, Rosen RM, Murphy KJ, Bohn P, Keys SA, Vapnik T (1994/5) Double-blind pilot trial of desipramine versus fluoxetine in panic patients. Anxiety 1:287-290.
12. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335:1010-1015.
13. Coplan JD, Gorman JM, Klein DF (1992) Serotonin related functions in panic-anxiety: A critical overview. Neuropsychopharmacology 6:189-200.
14. Coplan JD, Papp LA, Pine DS, Klein DF, Gorman JM (1996) SSRIs normalize noradrenergic function in panic (Poster). Annual Meeting of the American Psychiatric Association.
15. Coupland NJ, Bell CJ, Potokar JP (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16:356-362.
16. de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R (1995) Treatment of panic disorder with agoraphobia: Comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 152:683-691.
17. de Montigny C, Chaput Y, Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51:4-8.
18. den Boer JA, Westenberg HG (1988) Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: A double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 3:59-74.
19. den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS (1987) Effect of serotonin uptake inhibitors in anxiety disorders; A double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 2:21-32.
20. Eaton WW, Kessler RC, Wittchen HU, Magee WJ (1994) Panic and panic disorder in the United States. Am J Psychiatry 151:413-420.
21. Evans L, Bert J, Moore G, Cox J (1980) Zimelidine: A serotonin uptake blocker in the treatment of phobic anxiety. Prog Neuropsychopharmacol 4:75-79.
22. Evans L, Kenardy J, Schneider P, Hoey H (1986) Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Acta Psychiatr Scand 73:49-53.
23. Fahy TJ, O'Rourke D, Brophy J, Schazmann W, Sciascia S (1992) The Galway Study of Panic Disorder. I. Clomipramine and lofepramine in DSM III-R panic disorder: A placebo controlled trial. J Affect Disord 25:63-75 [published erratum appears in J Affect Disord, July, 1992, 25(3):214].
24. Goddard AW, Charney DS (1997) Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 58:4-12.
25. Goddard AW, Woods SW, Sholomskas DE, Goodman WK, Charney DS, Heninger GR (1993) Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-indueed anxiety in panic disorder. Psychiatry Res 48:119-133.
26. Goodwin GM (1996) How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. J Clin Psychiatry 4:9-13.
27. Gorman J, Wolkow R (1994) Sertraline as a treatment for panic disorder. Neuropsychopharmacology 10:117-175, 1975.
28. Gorman JM, Liebowitz MR, Fyer AJ, Goetz D, Campeas RB, Fyer MR, Davies SO, Klein DF (1987) An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 7:329-332 [published erratum appears in J Clin Psychopharmacol, Feb., 1988, 8(1):13].
29. Grove G, Coplan JD, Hollander E (1997) The neuroanatomy of 5-HT dysregulation and panic disorder. J Neuropsychiatry Clin Neurosci 9:198-207.
30. Hoehn-Saric R, McLeod DR, Hipsley PA (1993) Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 13:321-326.
31. Humble M, Wistedt B (1992) Serotonin, panic disorder and agoraphobia: Short-term and long-term efficacy of citalopram in panic disorders. Int Clin Psychopharmacol 5:21-39.
32. Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 2:33-45.
33. Kalus O, Asnis GM, Rubinson E, Kahn R, Friedman JM, Iqbal N, Grosz D, van Praag H, Cahn W (1991) Desiprarnine treatment in panic disorder. J Affect Disord 21:239-244.
34. Keller MB, Hanks DL (1993) Course and outcome in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 17:551-570.
35. Koczkas S (1983) Zimelidine treatment in phobias: A placebo-controlled study with a selective 5-HT reuptake inhibitor. World Congress of Psychiatry (poster presentation), Vienna, Austria.
36. Koczkas S, Holmberg G, Wedin L (1981) A pilot study of the effect of the 5-HT uptake inhibitor, zimelidine, on phobic anxiety. Acta Psychiatr Scand 63:328-341.
37. Landry P, Roy L (1997) Withdrawal hypomania associated with paroxetine (Letter). J Clin Psychopharmacol 17:60-61.
38. Lecrubier Y, Judge R (1997) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatr Scand 95:153-160.
39. Lecrubier Y, Bakker A, Dunbar G, Judge R (1997) A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatr Scand 95:145-152.
40. Louie AK, Lewis TB, Lannon RA (1993) Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 54:435-438.
41. Lydiard RB, Morton WA, Emmanuel NP, Zealberg JJ, Laraia MT, Stuart GW, O'Neil PM, Ballenger JC (1993) Preliminary report: Placebo-controlled, double-blind study of the clinical and meta-bolic effects of desipramine in panic disorder. Psychopharmacol Bull 29:183-188.
42. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL (1989) Quality of life in panic disorder. Arch Gen Psychiatry 46:984-992.
43. Ninan PT (1997) Issue in the assessment of treatment response in panic disorder with special reference to fluvoxamine. J Clin Psychiatry 58:24-31.
44. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM (1995) Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. Br J Psychiatry 167:374-379.
45. Panic Consensus Statement (1991) Treatment of Panic Disorder. NIH Consensus Development Conference, National Institutes of Health, Bethesda, MD.
46. Pecknold JC, Luthe L, Iny L, Ramdoyal D (1995) Fluoxetine in panic disorder: Pharmacologic and tritiated platelet imipramine and paroxetine binding study. J Psychiatry Neurosci 20:193-198.
47. Pollack MH, Otto MW (1997) Long-term course and outcome of panic disorder. J Clin Psychiatry 2:57-60.
48. 2 challenge. J Clin Psychiatry 57:539-42.
49. Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF (1990) Fluoxetine in panic disorder. J Clin Psychopharmacol 10:119-121.
50. Sharp DM, Power KG, Simpson RJ, Swanson V, Moodie E, Anstee JA, Ashford JJ (1996) Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord 10:219-242.
51. Shear MK, Maser JD (1994) Standardized assessment for panic disorder research. A conference report. Arch Gen Psychiatry 51:346-354.
52. Sheehan DV, Dunbar G (1996) The treatment of panic disorder with paroxetine. In Gotestam KG MP, Sheehan DV et al. (eds): Proceedings of the Second Novo Nordisk Symposium on Panic Disorder and OCD. Medical Forum International, The Netherlands, pp 29-38.
53. Sheehan DV, Harnett-Sheehan K (1996) The role of SSRIs in panic disorder. J Clin Psychiatry 10:51-58.
54. Steiner M, Oakes R, Gergel IP et al. (1995) A fixed dose study of paroxetine and placebo in the treatment in panic disorder. 148th Annual Meeting of the American Psychiatric Association. New-Research Abstracts, Miami, FL.
55. Tyrer P, Candy J, Kelly D (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia 32:237-254.
56. van Megen H, Westenberg H, den Boer J (1994) Effect of the selective serotonin reuptake inhibitor fluvoxamine of CCK-4 induced panic attacks. Neuropsychopharmacology 10:12S.
57. van Vliet IM, den Boer JA, Westenberg HG, Slaap BR (1996) A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder. J Clin Psychopharmacol 16:299-306.
58. Wade AG (1995) The optimum therapeutical area for SSRIs: Panic disorder (Abstract). VIIIth Congress of the European College of Neuropsychopharmacology, Venice, Italy.
59. Weissman MM, Klerman GL, Markowitz JS, Ouellette R (1989) Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 321:1209-1214.
60. Westenberg HG, den Boer JA (1989) Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacol Bull 25:119-123.
61. Westenberg HG, den Boer JA (1993) New findings in the treatment of panic disorder. Pharmacopsychiatry 1:30-33.
62. Wiborg IM, Dahl AA (1996) Does brief dynamic psychotherapy reduce the relapse rate of panic disorder? Arch Gen Psychiatry 53:689-694.